Prostate Cancer Incidence and Mortality among Men using Statins and Non-statin Lipid-lowering Medications

BACKGROUND: Statins have demonstrated protection against aggressive/late-stage and/or lethal prostate cancer (PC), but prior studies are limited by small populations, short follow-up, and unequal health care access. Research has not demonstrated that non-statin lipid-lowering medications (NSLLM) pro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Cancer
Auteurs principaux: Van Rompay, Maria I., Solomon, Keith R., Nickel, J. Curtis, Ranganathan, Gayatri, Kantoff, Philip W., McKinlay, John B.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501826/
https://ncbi.nlm.nih.gov/pubmed/30850323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2018.11.033
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires